ArticleBMC cancer2019

miR-23b and miR-27b are oncogenic microRNAs in breast cancer: evidence from a CRISPR/Cas9 deletion study.

Bethany N Hannafon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.